Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

893 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 1 study).
Takahashi Y, Nomoto H, Yokoyama H, Takano Y, Nagai S, Tsuzuki A, Cho KY, Miya A, Kameda H, Takeuchi J, Taneda S, Kurihara Y, Atsumi T, Nakamura A, Miyoshi H; SWITCH-SEMA 1 study group. Takahashi Y, et al. Among authors: kurihara y. Diabetes Obes Metab. 2023 Jun;25(6):1503-1511. doi: 10.1111/dom.14998. Epub 2023 Feb 28. Diabetes Obes Metab. 2023. PMID: 36722623 Clinical Trial.
Step-up therapy with biphasic insulin aspart-70/30--Sapporo 1-2-3 study.
Yoshioka N, Kurihara Y, Manda N, Komori K, Kato M, Kijima H, Wada N, Yanagisawa K, Aoki S, Ono Y, Koike T. Yoshioka N, et al. Among authors: kurihara y. Diabetes Res Clin Pract. 2009 Jul;85(1):47-52. doi: 10.1016/j.diabres.2009.04.012. Epub 2009 May 7. Diabetes Res Clin Pract. 2009. PMID: 19427051 Free article.
A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2).
Nomoto H, Miyoshi H, Furumoto T, Oba K, Tsutsui H, Miyoshi A, Kondo T, Tsuchida K, Atsumi T, Manda N, Kurihara Y, Aoki S; SAIS Study Group. Nomoto H, et al. Among authors: kurihara y. PLoS One. 2015 Aug 18;10(8):e0135854. doi: 10.1371/journal.pone.0135854. eCollection 2015. PLoS One. 2015. PMID: 26284918 Free PMC article. Clinical Trial.
A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1).
Nomoto H, Miyoshi H, Furumoto T, Oba K, Tsutsui H, Inoue A, Atsumi T, Manda N, Kurihara Y, Aoki S; SAIS Study Group. Nomoto H, et al. Among authors: kurihara y. PLoS One. 2016 Oct 6;11(10):e0164255. doi: 10.1371/journal.pone.0164255. eCollection 2016. PLoS One. 2016. PMID: 27711199 Free PMC article. Clinical Trial.
Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40).
Yokoyama H, Oishi M, Takamura H, Yamasaki K, Shirabe SI, Uchida D, Sugimoto H, Kurihara Y, Araki SI, Maegawa H. Yokoyama H, et al. Among authors: kurihara y. BMJ Open Diabetes Res Care. 2016 Oct 3;4(1):e000294. doi: 10.1136/bmjdrc-2016-000294. eCollection 2016. BMJ Open Diabetes Res Care. 2016. PMID: 27752329 Free PMC article.
Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial.
Miya A, Nakamura A, Miyoshi H, Cho KY, Nagai S, Kurihara Y, Aoki S, Taguri M, Terauchi Y, Atsumi T. Miya A, et al. Among authors: kurihara y. J Diabetes Investig. 2018 Jan;9(1):119-126. doi: 10.1111/jdi.12654. Epub 2017 Jul 10. J Diabetes Investig. 2018. PMID: 28296201 Free PMC article. Clinical Trial.
The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3).
Kitao N, Miyoshi H, Furumoto T, Ono K, Nomoto H, Miya A, Yamamoto C, Inoue A, Tsuchida K, Manda N, Kurihara Y, Aoki S, Nakamura A, Atsumi T; SAIS Study Group. Kitao N, et al. Among authors: kurihara y. Cardiovasc Diabetol. 2017 Oct 10;16(1):125. doi: 10.1186/s12933-017-0607-6. Cardiovasc Diabetol. 2017. PMID: 29017497 Free PMC article. Clinical Trial.
Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes-Randomized controlled study.
Oita M, Miyoshi H, Ono K, Nakamura A, Cho KY, Nomoto H, Yamamoto K, Omori K, Manda N, Kurihara Y, Aoki S, Atsumi T. Oita M, et al. Among authors: kurihara y. Endocr J. 2018 Feb 26;65(2):141-150. doi: 10.1507/endocrj.EJ17-0303. Epub 2017 Oct 31. Endocr J. 2018. PMID: 29093280 Free article. Clinical Trial.
Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea.
Omori K, Nomoto H, Nakamura A, Takase T, Cho KY, Ono K, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H. Omori K, et al. Among authors: kurihara y. J Diabetes Investig. 2019 Mar;10(2):367-374. doi: 10.1111/jdi.12889. Epub 2018 Sep 15. J Diabetes Investig. 2019. PMID: 29963781 Free PMC article. Clinical Trial.
893 results